SPC Financial Inc. Reduces Stock Position in SPDR S&P Biotech ETF (NYSEARCA:XBI)

SPC Financial Inc. cut its holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 2.4% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 6,511 shares of the exchange traded fund’s stock after selling 161 shares during the period. SPC Financial Inc.’s holdings in SPDR S&P Biotech ETF were worth $643,000 as of its most recent SEC filing.

Other institutional investors also recently bought and sold shares of the company. ORG Partners LLC acquired a new position in shares of SPDR S&P Biotech ETF in the 2nd quarter valued at $40,000. ORG Wealth Partners LLC acquired a new position in SPDR S&P Biotech ETF in the third quarter valued at $44,000. Resources Management Corp CT ADV grew its holdings in shares of SPDR S&P Biotech ETF by 30.3% during the second quarter. Resources Management Corp CT ADV now owns 593 shares of the exchange traded fund’s stock worth $55,000 after purchasing an additional 138 shares during the last quarter. SOA Wealth Advisors LLC. increased its position in shares of SPDR S&P Biotech ETF by 79.8% during the first quarter. SOA Wealth Advisors LLC. now owns 597 shares of the exchange traded fund’s stock worth $57,000 after purchasing an additional 265 shares in the last quarter. Finally, Lynx Investment Advisory purchased a new stake in shares of SPDR S&P Biotech ETF in the 2nd quarter valued at about $58,000.

SPDR S&P Biotech ETF Stock Down 0.9 %

NYSEARCA:XBI opened at $99.30 on Friday. The company has a market capitalization of $7.57 billion, a PE ratio of 11.47 and a beta of 1.11. SPDR S&P Biotech ETF has a 52-week low of $63.80 and a 52-week high of $103.52. The stock’s 50 day moving average price is $99.00 and its 200 day moving average price is $94.31.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.